Fixemer and coworkers studied 132 prostate cancer patients and showed significantly decreased levels of ERβ expression in 30 of 47 patients with high-grade prostatic intraepithelial neoplasia [101]. The gene discussed is ESR2; the disease is Familial prostate cancer.